Evidence map›Paper›PMID 29101768›Full record

ArticlePreventing chronic disease2017

Novel Methods and Data Sources for Surveillance of State-Level Diabetes and Prediabetes Prevalence.

Russ Mardon, David Marker, Jennifer Nooney, Joanne Campione, Frank Jenkins, Maurice Johnson, Lori Merrill, Deborah B Rolka, Sharon Saydah, Linda S Geiss and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Preventing chronic disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Imaging evaluation of the pancreas in diabetic patients.Abdominal radiology (New York) · 2022
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Russ MardonWestat, Inc, 1600 Research Blvd, RB 1170, Rockville, MD 20850. Email: RussMardon@westat.com.
David MarkerWestat, Inc, Rockville, Maryland.
Jennifer NooneyWestat, Inc, Rockville, Maryland.
Joanne CampioneWestat, Inc, Rockville, Maryland.
Frank JenkinsWestat, Inc, Rockville, Maryland.
Maurice JohnsonWestat, Inc, Rockville, Maryland.
Lori MerrillWestat, Inc, Rockville, Maryland.
Deborah B RolkaCenters for Disease Control and Prevention, Atlanta, Georgia.
Sharon SaydahCenters for Disease Control and Prevention, Atlanta, Georgia.
Linda S GeissCenters for Disease Control and Prevention, Atlanta, Georgia.
Xuanping ZhangCenters for Disease Control and Prevention, Atlanta, Georgia.
Sundar ShresthaCenters for Disease Control and Prevention, Atlanta, Georgia.
Westat (United States) · USCenters for Disease Control and Prevention · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

States bear substantial responsibility for addressing the rising rates of diabetes and prediabetes in the United States. However, accurate state-level estimates of diabetes and prediabetes prevalence that include undiagnosed cases have been impossible to produce with traditional sources of state-level data. Various new and nontraditional sources for estimating state-level prevalence are now available. These include surveys with expanded samples that can support state-level estimation in some states and administrative and clinical data from insurance claims and electronic health records. These sources pose methodologic challenges because they typically cover partial, sometimes nonrandom subpopulations; they do not always use the same measurements for all individuals; and they use different and limited sets of variables for case finding and adjustment. We present an approach for adjusting new and nontraditional data sources for diabetes surveillance that addresses these limitations, and we present the results of our proposed approach for 2 states (Alabama and California) as a proof of concept. The method reweights surveys and other data sources with population undercoverage to make them more representative of state populations, and it adjusts for nonrandom use of laboratory testing in clinically generated data sets. These enhanced diabetes and prediabetes prevalence estimates can be used to better understand the total burden of diabetes and prediabetes at the state level and to guide policies and programs designed to prevent and control these chronic diseases.

Indexed as

BiasDiabetes MellitusHumansInformation Storage and RetrievalPopulation SurveillancePrediabetic StatePrevalenceUnited States

Identifiers

PMID29101768
PMCPMC5672889
OpenAlexW2766616628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.